药物开发 药物开发
Xiaolei Zhu1, Jing Huang2, Yun Xu3
1Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
在缺血性中风模型中,obacunone (OB) 减少神经炎症和脑损伤. 这种天然化合物减轻了认知障碍,显示了作为中风治疗治疗剂的潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 微质驱动的神经炎症是缺血性中风发病的关键.
- 奥巴库农 (OB) 是一种类三聚胺,具有抗炎和抗氧化作用.
研究的目的:
- 为了研究OB在缺血性中风的治疗潜力.
- 阐明OB在缓解神经炎症和脑损伤方面的机制.
主要方法:
- 在体外:微质的OB预处理,然后进行LPS或OGD刺激.
- 在体内:在中脑动脉封闭 (MCAO) 鼠标模型中进行OB施用.
- 检测方法:qPCR,ELISA,西斑,神经行为测试,TTC染色,免疫光,网络药理学.
主要成果:
- OB抑制了NF-κB通路的激活,并减少了炎症性细胞因子的释放.
- 在MCAO小鼠中,OB减弱的缺血性脑损伤和认知缺陷.
- 通过网络药理学和结合性分析,MAPK1/ERK2被确定为潜在的OB目标.
结论:
- 它有效地缓解神经炎症和缺血损伤.
- 作为治疗缺血性中风治疗的治疗剂,OB显示出前途.
更多相关视频
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
05:45Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
Published on: October 10, 2025
相关概念视频
Preclinical Development: Overview
Clinical Trials: Overview
Drug Discovery: Overview
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
In Vitro Drug Release Testing: Overview, Development and Validation
Drug Regulation
